Clinical Trials Directory

Trials / Completed

CompletedNCT02761109

Postoperative Complications After Liver Transplantation

Postoperative Renal, Pulmonary, Cardiovascular Complications and Use of Blood Components in Patients Undergoing Liver Transplantation

Status
Completed
Phase
Study type
Observational
Enrollment
1,600 (actual)
Sponsor
Azienda Ospedaliera S. Maria della Misericordia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Incidence and risk factors for renal, cardiovascular and pulmonary complications after liver transplantation are not well defined. Blood products requirement is an important aspect of orthotropic liver transplantation (OLTx) management and has a great impact on patient's outcome. Transfusions of blood products increase perioperative complications and reduce graft and patients survival. The primary endpoint of the study is to evaluate the incidence of renal complication during ICU stay after liver transplantation using RIFLE criteria; secondary endpoint is to evaluate the incidence of cardiovascular and pulmonary complications. In addition patients' survival and the relationship between blood components use with the development of post-operative complications are evaluated.

Detailed description

It is conducted a prospective observational cohort study in all Italian liver transplant centers. Adult (\> 18 years old) recipients of deceased liver graft between January 2011 and December 2013 were eligible for inclusion. Exclusion criteria were the use of living organ donation, retransplantation, pediatric transplantations, combined transplantation and fulminant hepatic failure. Investigators collected data using a prospectively maintained computer database managed by the Italian Ministry of Health "Centro Nazionale Trapianti". Anesthetic and perioperative management followed the routine local institution protocols.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2020-01-01
Completion
2020-01-01
First posted
2016-05-04
Last updated
2020-01-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02761109. Inclusion in this directory is not an endorsement.